Satsuma Pharmaceuticals Inc (STSA) is unmoved Thursday morning, with the stock flat 0.00% in pre-market trading to 1.06. STSA's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 93 out of 146 industries, Satsuma Pharmaceuticals Inc ranks higher than 38% of stocks. Satsuma Pharmaceuticals Inc has risen 47.22% over the past month, closing at $0.70 on April 13. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.
STSA has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on STSA!